Labeler
AvKARE NDC Codes
AvKARE lists 374 finished drug products in the FDA NDC Directory under NDC labeler codes 42291, 73190.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Dasatinib, Lisdexamfetamine Dimesylate, Amlodipine Besylate and Benazepril Hydrochloride, brivaracetam, Eltrombopag Olamine, Deflazacort, Tacrolimus, Tapentadol Hydrochloride, Tofacitinib, Famciclovir, olmesartan medoxomil-hydrochlorothiazide, Sacubitril and Valsartan, Risperidone, Verapamil Hydrochloride, Mirabegron
- Active ingredients
- Dasatinib, Lisdexamfetamine dimesylate, Amlodipine besylate, Benazepril hydrochloride, Brivaracetam, Eltrombopag olamine, Deflazacort, Tacrolimus, Tapentadol hydrochloride, Tofacitinib citrate, Famciclovir, Olmesartan medoxomil
- NDC labeler codes
- 42291, 73190
- Strengths (from the 100 most recently listed products)
- Benazepril hydrochloride 10 mg/1; Benazepril hydrochloride 20 mg/1; Amlodipine besylate 5 mg/1; Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1; Metaxalone 800 mg/1; Tacrolimus .5 mg/1; Tacrolimus 1 mg/1; Tacrolimus 5 mg/1; Verapamil hydrochloride 120 mg/1; Verapamil hydrochloride 80 mg/1; Mirabegron 25 mg/1; Mirabegron 50 mg/1; Amlodipine besylate 2.5 mg/1; Amlodipine besylate 10 mg/1; Dutasteride .5 mg/1; Tapentadol hydrochloride 75 mg/1; Tapentadol hydrochloride 50 mg/1; Tapentadol hydrochloride 100 mg/1; Lacosamide 10 mg/mL
- Dosage forms
- Tablet, Film coated, Capsule, Tablet, Tablet, Orally disintegrating, Tablet, Film coated, Extended release, Capsule, Extended release, Solution, Suspension, Tablet, Extended release
- Routes
- Oral
- Drug classes (FDA established)
- Kinase Inhibitor, Calcium Channel Blocker, Angiotensin 2 Receptor Blocker, Central Nervous System Stimulant, Angiotensin Converting Enzyme Inhibitor, Dihydropyridine Calcium Channel Blocker, Thrombopoietin Receptor Agonist, Corticosteroid, Serotonin-3 Receptor Antagonist, Calcineurin Inhibitor Immunosuppressant, Opioid Agonist, Janus Kinase Inhibitor, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Thiazide Diuretic, Neprilysin Inhibitor, Atypical Antipsychotic, beta3-Adrenergic Agonist, Iron Chelator, Phosphodiesterase 4 Inhibitor, Thyroid Hormone Synthesis Inhibitor, Sodium-Glucose Cotransporter 2 Inhibitor, Cephalosporin Antibacterial, Muscle Relaxant, Serotonin Reuptake Inhibitor, Peroxisome Proliferator Receptor alpha Agonist, Progesterone, Phosphate Binder, Serotonin-1b and Serotonin-1d Receptor Agonist, Phosphodiesterase 5 Inhibitor, Serotonin-4 Receptor Agonist, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, 5-alpha Reductase Inhibitor, Influenza A M2 Protein Inhibitor, Antimalarial, Antiprotozoal, Sulfone, alpha-Adrenergic Blocker, P2Y12 Platelet Inhibitor, Tetracycline-class Drug, Osmotic Laxative, Potassium Salt, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Blood Coagulation Factor, Cholinergic Muscarinic Antagonist, Antimetabolite Immunosuppressant
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 117 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Isradipine | Isradipine 2.5 mg/1 | CapsuleOral | 42291-062 | 42291-0062-01 | — |
| Zafemynorelgestromin and ethinyl estradiol | Norelgestromin 150 ug/d; Ethinyl estradiol 35 ug/d | PatchTransdermal | 42291-930 | 42291-0930-03 | — |
| Acebutolol Hydrochloride | Acebutolol hydrochloride 200 mg/1 | CapsuleOral | 42291-010 | 42291-0010-01 | — |
| Teriflunomide | Teriflunomide 7 mg/1 | Tablet, Film coatedOral | 42291-830 | 42291-0830-30 | — |
| Teriflunomide | Teriflunomide 14 mg/1 | Tablet, Film coatedOral | 42291-831 | 42291-0831-30 | — |
| Posaconazole | Posaconazole 100 mg/1 | Tablet, Delayed releaseOral | 42291-919 | 42291-0919-60 | — |
| Bexarotene | Bexarotene 75 mg/1 | CapsuleOral | 42291-072 | 42291-0072-01 | — |
| Theophylline | Theophylline anhydrous 300 mg/1 | Tablet, Extended releaseOral | 42291-922 | 42291-0922-01 | — |
| Azathioprine | Azathioprine 100 mg/1 | TabletOral | 42291-063 | 42291-0063-01 | — |
| Zafirlukast | Zafirlukast 20 mg/1 | Tablet, CoatedOral | 42291-971 | 42291-0971-60 | — |
| Zafirlukast | Zafirlukast 10 mg/1 | Tablet, CoatedOral | 42291-970 | 42291-0970-60 | — |
| Fenofibrate | Fenofibrate 160 mg/1 | Tablet, Film coatedOral | 42291-427 | 42291-0427-5042291-0427-90 | — |
| Anastrozole | Anastrozole 1 mg/1 | TabletOral | 42291-016 | 42291-0016-3042291-0016-90 | — |
| Silodosin | Silodosin 4 mg/1 | CapsuleOral | 42291-777 | 42291-0777-30 | — |
| Silodosin | Silodosin 8 mg/1 | CapsuleOral | 42291-778 | 42291-0778-90 | — |
| etravirine | Etravirine 100 mg/1 | TabletOral | 42291-473 | 42291-0473-12 | — |
| etravirine | Etravirine 200 mg/1 | TabletOral | 42291-474 | 42291-0474-60 | — |
| Losartan Potassium and Hydrochlorothiazide | Losartan potassium 50 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 42291-502 | 42291-0502-1042291-0502-90 | — |
| Losartan Potassium and Hydrochlorothiazide | Losartan potassium 100 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 42291-503 | 42291-0503-1042291-0503-90 | — |
| Losartan Potassium and Hydrochlorothiazide | Losartan potassium 100 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 42291-504 | 42291-0504-1042291-0504-90 | — |
| Mirtazapine | Mirtazapine 7.5 mg/1 | TabletOral | 42291-494 | 42291-0494-3042291-0494-90 | — |
| Carbidopa and levodopa | Carbidopa 10 mg/1; Levodopa 100 mg/1 | TabletOral | 42291-471 | 42291-0471-0142291-0471-50 | — |
| Atomoxetine | Atomoxetine hydrochloride 25 mg/1 | CapsuleOral | 42291-066 | 42291-0066-30 | — |
| Atomoxetine | Atomoxetine hydrochloride 10 mg/1 | CapsuleOral | 42291-064 | 42291-0064-30 | — |
| Atomoxetine | Atomoxetine hydrochloride 18 mg/1 | CapsuleOral | 42291-065 | 42291-0065-30 | — |
| Atomoxetine | Atomoxetine hydrochloride 100 mg/1 | CapsuleOral | 42291-070 | 42291-0070-30 | — |
| Atomoxetine | Atomoxetine hydrochloride 40 mg/1 | CapsuleOral | 42291-067 | 42291-0067-30 | — |
| Atomoxetine | Atomoxetine hydrochloride 60 mg/1 | CapsuleOral | 42291-068 | 42291-0068-30 | — |
| Atomoxetine | Atomoxetine hydrochloride 80 mg/1 | CapsuleOral | 42291-069 | 42291-0069-30 | — |
| cilostazol | Cilostazol 100 mg/1 | TabletOral | 42291-453 | 42291-0453-60 | — |
| Azithromycin | Azithromycin dihydrate 500 mg/1 | Tablet, Film coatedOral | 42291-083 | 42291-0083-0342291-0083-30 | — |
| Azithromycin | Azithromycin dihydrate 250 mg/1 | Tablet, Film coatedOral | 42291-082 | 42291-0082-0642291-0082-30 | — |
| Primidone | Primidone 250 mg/1 | TabletOral | 42291-511 | 42291-0511-01 | — |
| Primidone | Primidone 50 mg/1 | TabletOral | 42291-509 | 42291-0509-50 | — |
| Carbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | 42291-472 | 42291-0472-0142291-0472-10 | — |
| Eplerenone | Eplerenone 25 mg/1 | Tablet, CoatedOral | 42291-454 | 42291-0454-90 | — |
| Eplerenone | Eplerenone 50 mg/1 | Tablet, CoatedOral | 42291-455 | 42291-0455-90 | — |
| Lithium Carbonate ERlithium carbonate | Lithium carbonate 450 mg/1 | TabletOral | 42291-496 | 42291-0496-01 | — |
| Azathioprine | Azathioprine 50 mg/1 | TabletOral | 42291-071 | 42291-0071-01 | — |
| Furosemide | Furosemide 40 mg/1 | TabletOral | 42291-469 | 42291-0469-0142291-0469-1042291-0469-90 | — |
| Furosemide | Furosemide 20 mg/1 | TabletOral | 42291-468 | 42291-0468-0142291-0468-1042291-0468-90 | — |
| Furosemide | Furosemide 80 mg/1 | TabletOral | 42291-470 | 42291-0470-0142291-0470-50 | — |
| Famciclovir | Famciclovir 250 mg/1 | Tablet, Film coatedOral | 42291-415 | 42291-0415-30 | — |
| Famciclovir | Famciclovir 125 mg/1 | Tablet, Film coatedOral | 42291-414 | 42291-0414-30 | — |
| Famciclovir | Famciclovir 500 mg/1 | Tablet, Film coatedOral | 42291-416 | 42291-0416-30 | — |
| Abiraterone Acetateabiraterone | Abiraterone acetate 500 mg/1 | TabletOral | 42291-073 | 42291-0073-60 | — |
| Sucralfatesucralfate oral | Sucralfate 1 g/10mL | SuspensionOral | 42291-781 | 42291-0781-42 | — |
| Azelastine Hydrochlorideazelastine | Azelastine hydrochloride 1 mg/mL | Spray, MeteredNasal | 42291-094 | 42291-0094-30 | — |
| Estradiol Vaginalestradiol | Estradiol .1 mg/g | CreamVaginal | 42291-426 | 42291-0426-42 | — |
| Tadalafil | Tadalafil 5 mg/1 | Tablet, Film coatedOral | 42291-865 | 42291-0865-30 | — |
AvKARE: common questions
- What is AvKARE's NDC labeler code?
- 42291, 73190. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for AvKARE?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.